These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8030091)
41. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hurley CK; Fernandez-Vina M; Hildebrand WH; Noreen HJ; Trachtenberg E; Williams TM; Baxter-Lowe LA; Begovich AB; Petersdorf E; Selvakumar A; Stastny P; Hegland J; Hartzman RJ; Carston M; Gandham S; Kollman C; Nelson G; Spellman S; Setterholm M Hum Immunol; 2007 Jan; 68(1):30-40. PubMed ID: 17207710 [TBL] [Abstract][Full Text] [Related]
42. [Human major histocompatibility complex: the HLA system]. Charron D; Khalil I Rev Prat; 1994 Jan; 44(1):20-7. PubMed ID: 8178053 [TBL] [Abstract][Full Text] [Related]
43. HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. Park KS; Park JS; Nam JH; Bang D; Sohn S; Lee ES Tissue Antigens; 2007 Feb; 69(2):139-44. PubMed ID: 17257316 [TBL] [Abstract][Full Text] [Related]
44. Comment on "MHC class II expression identifies functionally distinct human regulatory T cells". Swiatek-de Lange M; Rist W; Stahl HF; Weith A; Lenter MC J Immunol; 2008 Mar; 180(6):3625; author reply 3626. PubMed ID: 18322165 [No Abstract] [Full Text] [Related]
46. [Interview with Dominique Charron. What is going to happen tomorrow in the understanding of the functioning of HLA molecules?. Interview by P. Youinou]. Charron D Ann Med Interne (Paris); 1995; 146(1):25-8. PubMed ID: 7741390 [No Abstract] [Full Text] [Related]
47. [Immunogenetic risk factors in rheumatic diseases]. Matej N Klin Med (Mosk); 1989 Jul; 67(7):112-6. PubMed ID: 2811199 [No Abstract] [Full Text] [Related]
48. Retention of specific proliferative capacity of cloned human T cells alloactivated against HLA-D alleles. Pawelec G; Rehbein A; Alter BJ; Wernet P Immunogenetics; 1980; 11(5):527-32. PubMed ID: 6242887 [No Abstract] [Full Text] [Related]
49. Lessons from rat models on the genetic basis of interindividual differences in lymphocyte phenotype. Wonigeit K; Washington D; Hundrieser J Transplant Proc; 1998 Aug; 30(5):2341-3. PubMed ID: 9723496 [No Abstract] [Full Text] [Related]
50. Soluble HLA antigens and their peptides as immunoregulators and monitoring devices. Claas FH; van Rood JJ Hum Immunol; 1999 May; 60(5):398-400. PubMed ID: 10447396 [No Abstract] [Full Text] [Related]
51. Changes in the human thymus during aging. Steinmann GG Curr Top Pathol; 1986; 75():43-88. PubMed ID: 3514161 [No Abstract] [Full Text] [Related]
52. Allospecificity of liver allograft-derived lymphocytes and correlation with clinicopathologic findings. Markus BH; Demetris AJ; Fung JJ; Saidman S; Zeevi A; Starzl TE; Duquesnoy RJ Transplant Proc; 1988 Apr; 20(2):219-22. PubMed ID: 3284046 [No Abstract] [Full Text] [Related]
58. The role of the immunogenetic background in the development and recurrence of acute idiopathic pericarditis. Lazaros G; Karavidas A; Spyropoulou M; Tsiachris D; Halapas A; Zacharoulis A; Arapi S; Matzaraki V; Papadopoulos K; Korres D; Iniotaki A; Pyrgakis V; Stefanadis C Cardiology; 2011; 118(1):55-62. PubMed ID: 21411999 [TBL] [Abstract][Full Text] [Related]
59. HLA expression in myoblasts. Hohlfeld R; Engel AG Neurology; 1991 Dec; 41(12):2015. PubMed ID: 1745371 [No Abstract] [Full Text] [Related]
60. HLA class II display by circulating T lymphocytes in nonsteroidal anti-inflammatory nephritis induced by drugs. Ishikawa S; Hinoshita F; Ogura Y; Endo Y Nephron; 1995; 70(4):497-8. PubMed ID: 7477658 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]